HYBRID 2024
PRE-PROGRAM
“NEXT GENERATIONS OF GENE AND CELL THERAPIES”
February 8 and 9, 2024
2 DAYS : 4 SESSIONS
8 FEBRUARY 2024
8 FEBRUARY 2024Session 1 : 9:15pm - 12:15pm
The challenges associated with future viral vectors and genome editing approaches.
From the main challenges, avenues and prospects for new vectors to optimized delivery and safety, and tomorrow's genome-editing strategies
Session 2 : 02:30pm - 05:00pm
New nucleic acid therapies: applications, vectorization
From prophylactic to therapeutic vaccines and the various potential uses of nucleic acids. Challenges and barriers associated with the uses of nucleic acids: shelf life, route of administration, targeting, etc.
B2B Meetings : 12:15pm - 02:30pm & 5:00pm - 07:00pm
9 FEBRUARY 2024
Session 3
Immuno cell based therapies
How can the uses of CAR be extended beyond current applications? How can we improve delivery to solid
tumours, the role of the tumour environment, survival, etc.? Applications beyond cancer.
Session 4
Cell therapies and beyond
From the various therapeutic applications of cell therapies to exosomes: how to develop clinical uses of cell therapies, address characterisation issues, etc.? How to take full advantage of the coupling between therapeutic effect and vectorisation properties for exoxomes.
